Purcell Michael J.
SEC Form 4 insider trading activity
Purcell Michael J. has filed 7 SEC Form 4 filings (7 transaction rows) across 2 companies, including HEPA, IMXI, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Purcell Michael J. is listed as Director at Hepion Pharmaceuticals, Inc. Inside the rolling window, Purcell Michael J. reported 2 open-market purchases totaling $150K in HEPA and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,000,000 HEPA shares on Aug 3, 2026, worth $100K.
Companies traded
Other insiders at HEPA
Insider Buying
$150K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Purcell Michael J. made?
Purcell Michael J. has filed 7 SEC Form 4 filings (7 transaction rows) across 2 companies, including HEPA, IMXI since 2025.
Which companies does Purcell Michael J. trade?
Purcell Michael J. has filed SEC Form 4 disclosures for 2 companies, including HEPA, IMXI.
When was Purcell Michael J.'s most recent SEC Form 4 filing?
Purcell Michael J.'s most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Purcell Michael J.'s total buy and sell value in the current window?
Inside the rolling retention window, Purcell Michael J. bought $150K and sold $0 based on SEC Form 4 filings.
What was Purcell Michael J.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,000,000 HEPA shares on 2026-08-03, worth $100K, per SEC Form 4 filings.